By Regulatory Approvals — FDA clears Bayer’s Hyrnuo in first-line lung cancer, amping up Hernexeos rivalry Fierce Pharma
Read the original at Regulatory Approvals ↗
Auto-published by the finit.news Events monitor from Regulatory Approvals; summarized by AI and may contain errors — verify against the primary source. September 9, 2026.